학술논문
MANIFEST: Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
Document Type
Article
Author
Mascarenhas, J.; Kremyanskaya, M.; Hoffman, R.; Patriarca, A.; Palandri, F.; Devos, T.; Passamonti, F.; Rampal, R.K.; Mead, A.J.; Hobbs, G.; Scandura, J.M.; Talpaz, M.; Granacher, N.; Somervaille, T.C.P.; Wondergem, M.J.; Salama, M.E.; Colak, G.; Cui, J.; Kiladjian, J.-J.; Vannucchi, A.M.; Verstovsek, S.; Curto-García, N.; Harrison, C.; Gupta, V.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 November 2023, 41(32):4993-5004)
Subject
Language
English
ISSN
15277755
0732183X
0732183X